Our Mission

The Kanzius Cancer Research Foundation is a 501(c)(3) non-profit organization. It is made up of a group of dedicated individuals supporting ongoing research for the Kanzius Non-invasive Radio Wave Treatment project; a treatment without any side effects. Our mission is to create national and global awareness of the potentials of this treatment and to raise funds to help accelerate the speed at which research progresses through human trials. We believe that by acting together in support of continuing research and development, we can make a difference in the lives of people who suffer from this disease.

 

The Journey to Human Trials

Each and every day, the promise of finding a better way to treat cancer fuels the focus and tenacity of the Kanzius RF Laboratory team. Clinical trials conducted by...

Read More »

Spread the wave

We want everyone to know about the Kanzius Non-invasive Radio Wave Cancer Treatment and the amazing results that are being reported from the research labs.

Start spreading the wave »

Follow us on Facebook & Twitter

Become a fan of Kanzius Cancer Research Foundation on Facebook – follow us on Twitter. Be the first to know about breaking Kanzius research news, events, fundraisers and more.

Join us on Facebook » or follow us on Twitter »
 

Faces Of The Fight

Erie Federal Credit Union

For one Pennsylvania credit union, it would have been hard enough to lose an employee to cancer in July 2009. But, when it lost another employee two months later, the call to action couldn’t have been louder or clearer.

So, the Erie Federal Credit Union (EFCU) answered the call by creating a fundraiser that allowed any one of its members to raise money for KCRF.


Click here to view all Faces Of The Fight stories »

Latest News

New, larger Kanzius device ready for use
December 21

The next step in turning John Kanzius' cancer-killing dream into reality sits in a Millcreek Township laboratory.

A new, larger version of the late Millcreek inventor's external radio-frequency generator is finished and will be shipped in January to M.D. Anderson Cancer Center in Houston.

This fifth-generation device is big enough for M.D. Anderson researchers to use on larger animals and humans.

New Manuscript validates Kanzius Laboratory Group is the Worlds First to Deliver Nanoparticles to the Nucleus of a Cancer Cell.
January 26

Published January 2012 in Biomaterials

A new manuscript, “Internalization of C60 fullerenes into cancer cells with accumulation in the nucleus via the nuclear pore complex,” published in the journal Biomaterials, presents some exciting results related to the Kanzius radiofrequency field treatment.  The Kanzius/Curley Lab at MD Anderson is the first laboratory group in the world to demonstrate that they can get carbon nanoparticles (C60 fullerenes) into the nucleus of cells. DOWNLOAD HERE


Newsletter Sign-Up

 Receive via email only
 Receive via both email and postal mail